3-oxoglycyrrhetinic acid has been researched along with bavachinin in 1 studies
| Studies (3-oxoglycyrrhetinic acid) | Trials (3-oxoglycyrrhetinic acid) | Recent Studies (post-2010) (3-oxoglycyrrhetinic acid) | Studies (bavachinin) | Trials (bavachinin) | Recent Studies (post-2010) (bavachinin) |
|---|---|---|---|---|---|
| 10 | 0 | 6 | 35 | 0 | 33 |
| Protein | Taxonomy | 3-oxoglycyrrhetinic acid (IC50) | bavachinin (IC50) |
|---|---|---|---|
| Peroxisome proliferator-activated receptor gamma | Homo sapiens (human) | 0.6167 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ge, GB; Hao, DC; Hou, J; Jin, Q; Li, YG; Wang, P; Yang, L; Zhou, K; Zou, LW | 1 |
1 other study(ies) available for 3-oxoglycyrrhetinic acid and bavachinin
| Article | Year |
|---|---|
Design, synthesis, and structure-activity relationship study of glycyrrhetinic acid derivatives as potent and selective inhibitors against human carboxylesterase 2.
Topics: Carboxylesterase; Drug Design; Enzyme Inhibitors; Glycyrrhetinic Acid; Humans; Molecular Docking Simulation; Structure-Activity Relationship | 2016 |